T1	CHEM 16 27	dorzolamida
#1	AnnotatorNotes T1	C0165590; dorzolamide; Organic Chemical · Pharmacologic Substance
T2	PROC 744 757	aleatorizados
#2	AnnotatorNotes T2	C0034656; Randomization; Research Activity
T3	ANAT 51 60	retiniano
#3	AnnotatorNotes T3	C0035298; Retina; Body Part, Organ, or Organ Component | C1278894; Entire retina; Body Part, Organ, or Organ Component
T4	PROC 72 87	fotocoagulación
#4	AnnotatorNotes T4	C0023694; Light Coagulation; Therapeutic or Preventive Procedure | C0197041; Photocoagulation of eye; Therapeutic or Preventive Procedure
T5	DISO 94 117	edema macular diabético
#5	AnnotatorNotes T5	C0730285; Macular edema due to diabetes mellitus; Disease or Syndrome
T6	PROC 136 157	fotocoagulación focal
#6	AnnotatorNotes T6	C1302105; Focal photocoagulation; Therapeutic or Preventive Procedure
T7	DISO 172 185	fuga vascular
T8	ANAT 177 185	vascular
#7	AnnotatorNotes T8	C0005847; Blood Vessel; Body Part, Organ, or Organ Component | C1283786; Entire blood vessel; Body Part, Organ, or Organ Component
T9	DISO 192 215	edema macular diabético
#8	AnnotatorNotes T9	C0730285; Macular edema due to diabetes mellitus; Disease or Syndrome
T10	ANAT 232 262	epitelio pigmentario retiniano
#9	AnnotatorNotes T10	C0035322; Structure of retinal pigment epithelium; Body Part, Organ, or Organ Component | C1305324; Entire retinal pigment epithelium; Body Part, Organ, or Organ Component
T11	ANAT 303 309	retina
#10	AnnotatorNotes T11	C0035298; Retina; Body Part, Organ, or Organ Component | C1278894; Entire retina; Body Part, Organ, or Organ Component
T12	CHEM 349 360	dorzolamida
#11	AnnotatorNotes T12	C0165590; dorzolamide; Organic Chemical · Pharmacologic Substance
T13	CHEM 365 374	inhibidor
#12	AnnotatorNotes T13	C1999216; Inhibitor; Biologically Active Substance
T14	CHEM 388 407	anhidrasa carbónica
#13	AnnotatorNotes T14	C0007028; CARBONATE DEHYDRATASE; Amino Acid, Peptide, or Protein · Enzyme
T15	CHEM 441 452	dorzolamida
#14	AnnotatorNotes T15	C0165590; dorzolamide; Organic Chemical · Pharmacologic Substance
T16	PROC 470 477	placebo
#15	AnnotatorNotes T16	C0032042; Placebos; Therapeutic or Preventive Procedure
T17	PROC 881 895	agudeza visual
#16	AnnotatorNotes T17	C0200150; Visual acuity testing; Diagnostic Procedure | C0846620; Measurement of visual acuity; Diagnostic Procedure
T18	ANAT 502 511	retiniano
#17	AnnotatorNotes T18	C0035298; Retina; Body Part, Organ, or Organ Component | C1278894; Entire retina; Body Part, Organ, or Organ Component
T19	PROC 526 547	fotocoagulación focal
#18	AnnotatorNotes T19	C1302105; Focal photocoagulation; Therapeutic or Preventive Procedure
T20	DISO 555 578	edema macular diabético
#19	AnnotatorNotes T20	C0730285; Macular edema due to diabetes mellitus; Disease or Syndrome
T21	PROC 601 674	Estudio experimental, comparativo, prospectivo, longitudinal, doble ciego
#20	AnnotatorNotes T21	C0678323; experimentation; Research Activity + C1579762; comparative study research; Research Activity + C0033522; Prospective Studies; Research Activity + C0023981; Longitudinal Studies; Research Activity + C0013072; Double-Blind Method; Research Activity
T22	DISO 679 689	diabéticos
#21	AnnotatorNotes T22	C0011849; Diabetes Mellitus; Disease or Syndrome | C0241863; Diabetic; Finding | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T23	DISO 694 713	edema macular focal
T24	PROC 727 742	fotocoagulación
#22	AnnotatorNotes T24	C0023694; Light Coagulation; Therapeutic or Preventive Procedure | C0197041; Photocoagulation of eye; Therapeutic or Preventive Procedure
T25	CHEM 807 818	dorzolamida
#23	AnnotatorNotes T25	C0165590; dorzolamide; Organic Chemical · Pharmacologic Substance
T26	PROC 831 838	placebo
#24	AnnotatorNotes T26	C0032042; Placebos; Therapeutic or Preventive Procedure
T27	ANAT 932 939	macular
#25	AnnotatorNotes T27	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T28	PROC 968 983	fotocoagulación
#26	AnnotatorNotes T28	C0023694; Light Coagulation; Therapeutic or Preventive Procedure | C0197041; Photocoagulation of eye; Therapeutic or Preventive Procedure
T29	ANAT 1079 1083	ojos
#27	AnnotatorNotes T29	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T30	ANAT 1359 1366	macular
#28	AnnotatorNotes T30	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T31	CHEM 1521 1532	dorzolamida
#29	AnnotatorNotes T31	C0165590; dorzolamide; Organic Chemical · Pharmacologic Substance
T32	PROC 1582 1589	placebo
#30	AnnotatorNotes T32	C0032042; Placebos; Therapeutic or Preventive Procedure
T33	PROC 780 793	procedimiento
#31	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T34	ANAT 1613 1622	retiniano
#32	AnnotatorNotes T34	C0035298; Retina; Body Part, Organ, or Organ Component | C1278894; Entire retina; Body Part, Organ, or Organ Component
T35	PROC 1637 1658	fotocoagulación focal
#33	AnnotatorNotes T35	C1302105; Focal photocoagulation; Therapeutic or Preventive Procedure
T36	DISO 1662 1672	diabéticos
#34	AnnotatorNotes T36	C0011849; Diabetes Mellitus; Disease or Syndrome | C0241863; Diabetic; Finding | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T37	DISO 1677 1690	edema macular
#35	AnnotatorNotes T37	C0271051; Macular retinal edema; Disease or Syndrome
T38	ANAT 100 107	macular
#36	AnnotatorNotes T38	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T39	ANAT 561 568	macular
#37	AnnotatorNotes T39	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T40	ANAT 700 707	macular
#38	AnnotatorNotes T40	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T41	ANAT 1683 1690	macular
#39	AnnotatorNotes T41	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T42	ANAT 198 205	macular
#40	AnnotatorNotes T42	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T44	Route 375 381	tópico
#41	AnnotatorNotes T44	C1522168; Topical Route of Drug Administration; Functional Concept
T45	Duration 758 767	3 semanas
T47	Duration 940 953	3 y 6 semanas
T48	LIVB 1087 1096	pacientes
#42	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	Age 1135 1150	58.3 ± 8.3 años
T50	Duration 1550 1559	3 semanas
R1	Location_of Arg1:T38 Arg2:T5	
R2	Location_of Arg1:T8 Arg2:T7	
R3	Location_of Arg1:T42 Arg2:T9	
R4	Overlap Arg1:T7 Arg2:T9	
R5	Has_Route_or_Mode Arg1:T12 Arg2:T44	
T43	CONC 333 344	facilitarse
A1	Assertion T43 Speculated
R6	Causes Arg1:T12 Arg2:T43	
T46	Spec_cue 326 332	podría
R7	Speculation Arg1:T46 Arg2:T43	
T51	Observation 33 60	reducir el grosor retiniano
R8	Causes Arg1:T1 Arg2:T51	
R9	After Arg1:T51 Arg2:T4	
R10	After Arg1:T1 Arg2:T4	
R11	Location_of Arg1:T3 Arg2:T51	
T52	Observation 158 185	interrumpe la fuga vascular
R12	Causes Arg1:T6 Arg2:T52	
T53	Observation 484 511	reducir el grosor retiniano
R13	Causes Arg1:T15 Arg2:T53	
R14	Location_of Arg1:T18 Arg2:T53	
R15	After Arg1:T53 Arg2:T19	
R16	Location_of Arg1:T39 Arg2:T20	
R17	Before Arg1:T6 Arg2:T12	
R18	Overlap Arg1:T51 Arg2:T5	
R19	Overlap Arg1:T53 Arg2:T20	
R20	After Arg1:T15 Arg2:T19	
R21	After Arg1:T16 Arg2:T19	
R22	Location_of Arg1:T40 Arg2:T23	
R23	Overlap Arg1:T22 Arg2:T23	
R24	Before Arg1:T24 Arg2:T2	
R25	After Arg1:T2 Arg2:T33	
R26	Overlap Arg1:T2 Arg2:T45	
R27	Before Arg1:T24 Arg2:T25	
R28	Before Arg1:T33 Arg2:T25	
R29	Before Arg1:T33 Arg2:T26	
T54	CONC 897 921	grosor del punto central
T55	CONC 924 939	volumen macular
R30	Overlap Arg1:T55 Arg2:T47	
R31	Overlap Arg1:T54 Arg2:T47	
R32	Overlap Arg1:T17 Arg2:T47	
R33	After Arg1:T17 Arg2:T28	
R34	After Arg1:T54 Arg2:T28	
R35	After Arg1:T55 Arg2:T28	
T56	CONC 999 1012	t de Wilcoxon
#43	AnnotatorNotes T56	C0242931; Wilcoxon Rank Test; Quantitative Concept
T57	CONC 1030 1047	U de Mann-Whitney
#44	AnnotatorNotes T57	C0242927; Mann-Whitney U Test; Quantitative Concept
R36	Has_Age Arg1:T48 Arg2:T49	
T58	CONC 1199 1223	grosor del punto central
T59	CONC 1351 1366	volumen macular
R37	Has_Duration_or_Interval Arg1:T31 Arg2:T50	
R38	Has_Duration_or_Interval Arg1:T25 Arg2:T45	
R39	Has_Duration_or_Interval Arg1:T26 Arg2:T45	
R40	Has_Duration_or_Interval Arg1:T32 Arg2:T50	
T60	Observation 1595 1622	reducir el grosor retiniano
R41	Causes Arg1:T31 Arg2:T60	
R42	After Arg1:T60 Arg2:T35	
R43	After Arg1:T31 Arg2:T35	
R44	After Arg1:T32 Arg2:T35	
R45	Location_of Arg1:T34 Arg2:T60	
R46	Overlap Arg1:T36 Arg2:T37	
R47	Location_of Arg1:T41 Arg2:T37	
R48	Overlap Arg1:T60 Arg2:T37	
R49	Overlap Arg1:T60 Arg2:T36	
#45	AnnotatorNotes T23	C4324513; Macular focal edema; Disease or Syndrome
A2	Experiencer T48 Patient
